Mutations observed in melanoma are predominantly of the C > T transition type, due to the production of cyclobutane pyrimidine dimers (CPDs) in response to solar UV damage; however, other mutational classes (e.g., C > A transversions) have also been observed, such as those occurring in key driver genes such as BRAF and Kit [121]. The gene discussed is BRAF; the disease is melanoma.